CIK: 0001306923 · Show all filings
Period: Q2 2020 (← Previous) (Next →)
Filing Date: Aug 14, 2020
Total Value ($000): $1,665,451 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| — | IMMUNOMEDICS INC | 5,182,983 | $183,685 | 11.0% | $13.38 | — | COM | 452907108 |
| STAA | STAAR SURGICAL CO | 2,821,154 | $173,614 | 10.4% | $13.06 | +212.8% | COM | 852312305 |
| BMRN | BIOMARIN PHARMACEUTICAL INC | 1,405,950 | $173,410 | 10.4% | $80.19 | +23.9% | COM | 09061G101 |
| INSM | INSMED INC | 6,002,289 | $165,303 | 9.9% | $17.16 | +38.1% | COM | 457669307 |
| — | ABIOMED INC | 492,333 | $118,928 | 7.1% | $37.80 | — | COM | 003654100 |
| FOLD | AMICUS THERAPEUTICS INC | 7,334,714 | $110,607 | 6.6% | $7.59 | +60.5% | COM | 03152W109 |
| UTHR | UNITED THERAPEUTICS CORP | 766,406 | $92,735 | 5.6% | $88.73 | +26.8% | COM | 91307C102 |
| — | EPIZYME INC | 5,513,676 | $88,550 | 5.3% | $15.12 | — | COM | 29428V104 |
| — | KARYOPHARM THERAPEUTICS INC | 4,219,452 | $79,916 | 4.8% | $17.42 | — | COM | 48576U106 |
| ACAD | ACADIA PHARMACEUTICALS INC | 1,564,900 | $75,851 | 4.6% | $27.34 | +75.6% | COM | 004225108 |
| — | AIMMUNE THERAPEUTICS INC | 3,318,212 | $55,447 | 3.3% | $22.84 | — | COM | 00900T107 |
| — | ALEXION PHARMACEUTICALS INC | 444,629 | $49,905 | 3.0% | $121.54 | — | COM | 015351109 |
| — | MOMENTA PHARMACEUTICALS INC | 1,479,524 | $49,224 | 3.0% | $14.06 | — | COM | 60877T100 |
| VNDA | VANDA PHARMACEUTICALS INC | 4,116,548 | $47,093 | 2.8% | $11.21 | +1.0% | COM | 921659108 |
| — | REVANCE THERAPEUTICS INC | 1,704,372 | $41,621 | 2.5% | $21.02 | — | COM | 761330109 |
| — | CLOVIS ONCOLOGY INC | 4,361,411 | $29,440 | 1.8% | $48.59 | — | COM | 189464100 |
| — | SAGE THERAPEUTICS INC | 575,200 | $23,917 | 1.4% | $48.62 | — | COM | 78667J108 |
| — | AMAG PHARMACEUTICALS INC | 2,959,587 | $22,641 | 1.4% | $29.07 | — | COM | 00163U106 |
| ALGN | ALIGN TECHNOLOGY INC | 67,505 | $18,526 | 1.1% | $114.31 | +97.0% | COM | 016255101 |
| PBYI | PUMA BIOTECHNOLOGY INC | 1,343,897 | $14,017 | 0.8% | $28.26 | -63.4% | COM | 74587V107 |
| — | DICERNA PHARMACEUTICALS INC | 331,813 | $8,428 | 0.5% | $5.39 | — | COM | 253031108 |
| PRTA | PROTHENA CORP PLC | 771,065 | $8,065 | 0.5% | $32.98 | -66.3% | COM | G72800108 |
| — | RIGEL PHARMACEUTICALS INC | 3,542,551 | $6,483 | 0.4% | $3.40 | — | COM | 766559603 |
| KLDO | KALEIDO BIOSCIENCES INC | 786,400 | $5,843 | 0.4% | $13.76 | -51.3% | COM | 483347100 |
| CYTK | CYTOKINETICS INC | 123,686 | $2,915 | 0.2% | $6.71 | +179.3% | COM | 23282W605 |
| — | ZOGENIX INC | 104,100 | $2,812 | 0.2% | $23.14 | — | COM | 98978L204 |
| GOSS | GOSSAMER BIO INC | 204,214 | $2,655 | 0.2% | $12.58 | 0.0% | COM | 38341P102 |
| — | ATHENEX INC | 185,200 | $2,548 | 0.2% | $13.76 | — | COM | 04685N103 |
| SNDX | SYNDAX PHARMACEUTICALS INC | 127,700 | $1,893 | 0.1% | $12.20 | +24.8% | COM | 87164F105 |
| — | APREA THERAPEUTICS INC | 47,234 | $1,832 | 0.1% | $38.79 | — | COM | 03836J102 |
| — | MAGENTA THERAPEUTICS INC | 194,600 | $1,461 | 0.1% | $7.51 | — | COM | 55910K108 |
| — | ALIMERA SCIENCES INC | 200,919 | $1,266 | 0.1% | $6.30 | — | COM | 016259202 |
| — | KEZAR LIFE SCIENCES INC | 205,086 | $1,062 | 0.1% | $5.18 | — | COM | 49372L100 |
| — | INTRA-CELLULAR THERAPIES INC | 37,400 | $960 | 0.1% | $34.30 | — | COM | 46116X101 |
| — | RETROPHIN INC | 47,000 | $959 | 0.1% | $14.60 | — | COM | 761299106 |
| URGN | UROGEN PHARMA LTD | 24,500 | $640 | 0.0% | $27.01 | -9.5% | COM | M96088105 |
| — | MARINUS PHARMACEUTICALS INC | 125,321 | $318 | 0.0% | $4.17 | — | COM | 56854Q101 |
| — | SUNESIS PHARMACEUTICALS INC | 1,162,473 | $306 | 0.0% | $4.37 | — | COM | 867328700 |
| ALDX | ALDEYRA THERAPEUTICS INC | 73,500 | $306 | 0.0% | $7.53 | -51.5% | COM | 01438T106 |
| — | IDERA PHARMACEUTICALS INC | 77,044 | $138 | 0.0% | $8.90 | — | COM | 45168K405 |
| — | MINERVA NEUROSCIENCES INC | 36,319 | $131 | 0.0% | $5.62 | — | COM | 603380106 |